Maria Souli

4.4k total citations
71 papers, 3.3k citations indexed

About

Maria Souli is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Maria Souli has authored 71 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Medicine, 28 papers in Pharmacology and 23 papers in Epidemiology. Recurrent topics in Maria Souli's work include Antibiotic Resistance in Bacteria (49 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Antibiotic Use and Resistance (15 papers). Maria Souli is often cited by papers focused on Antibiotic Resistance in Bacteria (49 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Antibiotic Use and Resistance (15 papers). Maria Souli collaborates with scholars based in Greece, United States and South Korea. Maria Souli's co-authors include Helen Giamarellou, Irene Galani, Anastasia Antoniadou, Ilias Karaiskos, George L. Daikos, Apostolos Armaganidis, L. S. Tzouvelekis, Flora Kontopidou, Evangelos Papadomichelakis and Evangelos Koratzanis and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Maria Souli

70 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Souli Greece 32 2.5k 1.2k 919 773 670 71 3.3k
Irene Galani Greece 32 2.6k 1.0× 1.2k 1.0× 838 0.9× 696 0.9× 800 1.2× 77 3.3k
Simona Bratu United States 24 2.8k 1.1× 1.1k 0.9× 609 0.7× 702 0.9× 1.0k 1.5× 31 3.2k
Samuel K. Bouchillon United States 31 1.9k 0.8× 1.1k 0.9× 683 0.7× 825 1.1× 425 0.6× 51 2.6k
Robert E. Badal United States 32 2.2k 0.9× 887 0.8× 1.0k 1.1× 917 1.2× 695 1.0× 73 3.0k
Carl Urban United States 32 3.0k 1.2× 1.4k 1.2× 1.2k 1.3× 783 1.0× 1.1k 1.7× 94 4.2k
Michael J. Dowzicky United States 33 1.9k 0.8× 887 0.8× 609 0.7× 687 0.9× 394 0.6× 80 2.8k
José María Casellas Argentina 17 2.1k 0.9× 669 0.6× 752 0.8× 619 0.8× 714 1.1× 36 2.7k
Meredith Hackel United States 38 3.7k 1.5× 1.8k 1.6× 1.0k 1.1× 1.2k 1.6× 1.3k 1.9× 96 4.4k
Alexandre Prehn Zavascki Brazil 35 3.5k 1.4× 2.4k 2.0× 1.5k 1.7× 848 1.1× 629 0.9× 116 4.9k
Francesco Luzzaro Italy 34 3.5k 1.4× 826 0.7× 1.1k 1.2× 713 0.9× 1.5k 2.2× 112 4.3k

Countries citing papers authored by Maria Souli

Since Specialization
Citations

This map shows the geographic impact of Maria Souli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Souli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Souli more than expected).

Fields of papers citing papers by Maria Souli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Souli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Souli. The network helps show where Maria Souli may publish in the future.

Co-authorship network of co-authors of Maria Souli

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Souli. A scholar is included among the top collaborators of Maria Souli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Souli. Maria Souli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galani, Irene, et al.. (2024). In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. Journal of Antimicrobial Chemotherapy. 79(5). 1101–1108. 2 indexed citations
2.
3.
Komarow, Lauren, Damon W. Ellison, Andrey A. Filippov, et al.. (2023). Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing. Journal of Clinical Microbiology. 61(12). e0061423–e0061423. 10 indexed citations
4.
Galani, Irene, Παναγιώτα Γιαννοπούλου, Paraskevi Chra, et al.. (2019). Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece. Microbial Drug Resistance. 26(1). 9–13. 10 indexed citations
5.
Souli, Maria, Felicia Ruffin, Seong-Ho Choi, et al.. (2019). Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. Clinical Infectious Diseases. 69(11). 1868–1877. 77 indexed citations
6.
Tacconelli, Evelina, Fulvia Mazzaferri, Anne Marie G. A. de Smet, et al.. (2019). ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clinical Microbiology and Infection. 25(7). 807–817. 123 indexed citations
7.
Galani, Irene, et al.. (2019). In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016. European Journal of Clinical Microbiology & Infectious Diseases. 38(6). 1143–1150. 40 indexed citations
8.
Cyr, Derek D., Andrew S. Allen, Felicia Ruffin, et al.. (2017). Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping. Genes and Immunity. 18(2). 95–99. 23 indexed citations
9.
Souli, Maria, et al.. (2017). Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1305–1315. 44 indexed citations
10.
Karaiskos, Ilias, Maria Souli, & Helen Giamarellou. (2015). Plazomicin: an investigational therapy for the treatment of urinary tract infections. Expert Opinion on Investigational Drugs. 24(11). 1501–1511. 30 indexed citations
11.
Galani, Irene, Garyphallia Poulakou, Ioannis Katsarolis, et al.. (2012). Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum  -lactamase-producing Escherichia coli. Journal of Antimicrobial Chemotherapy. 67(10). 2424–2428. 34 indexed citations
12.
Souli, Maria, et al.. (2011). Screening of fungi implicated in the dieback of olive trees (Olea europea) in Chebika's area. 1(4). 33–38. 1 indexed citations
14.
Galani, Irene, et al.. (2010). Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece. International Journal of Antimicrobial Agents. 36(3). 252–254. 15 indexed citations
15.
Souli, Maria, Θωμάς Τσαγανός, Angelos Pefanis, et al.. (2010). Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model. Journal of Antimicrobial Chemotherapy. 66(3). 611–617. 19 indexed citations
16.
Panagea, Theofano, et al.. (2010). Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. International Journal of Antimicrobial Agents. 37(2). 124–128. 50 indexed citations
17.
Antoniadou, Anastasia, Flora Kontopidou, G. Poulakou, et al.. (2007). Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. Journal of Antimicrobial Chemotherapy. 59(4). 786–790. 203 indexed citations
18.
Souli, Maria, et al.. (2006). Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonisation in daycare centre attendees in Athens, Greece. International Journal of Antimicrobial Agents. 28(4). 297–301. 11 indexed citations
19.
Galani, Irene, et al.. (2005). Characterization of a new integron containing blaVIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece. Journal of Antimicrobial Chemotherapy. 55(5). 634–638. 40 indexed citations
20.
Galani, Irene, et al.. (2004). First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1. Clinical Microbiology and Infection. 10(8). 757–760. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026